Patents by Inventor Ana-Maria DRAGOI

Ana-Maria DRAGOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COVID-19 THERAPEUTICS AND METHODS OF TREATMENT
    Publication number: 20220409637
    Abstract: Therapeutics and methods of treating COVID-19 in a patient in need thereof comprising administering a pharmaceutically effective dose of a therapeutic, wherein the therapeutic contains an ACE2 externalizer, and the ACE2 externalizer is one of diminazene, diminazene aceturate, or a pharmaceutically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, or prodrug thereof.
    Type: Application
    Filed: September 6, 2022
    Publication date: December 29, 2022
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Johnathan Steven ALEXANDER, Christopher KEVIL, Mansoureh BARZEGAR, Ana Maria DRAGOI
  • COVID-19 THERAPEUTICS AND METHODS OF TREATMENT
    Publication number: 20210346409
    Abstract: Therapeutics and methods of treating COVID-19 in a patient in need thereof comprising administering a pharmaceutical composition containing a pharmaceutically effective dose of a therapeutic, wherein the therapeutic contains both an ACE2 externalizer and one or more ACE2 internalization preventors. Methods of treatment and pharmaceutical compositions comprising an ACE2 externalizer and one or more ACE2 internalization preventors.
    Type: Application
    Filed: May 7, 2021
    Publication date: November 11, 2021
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Johnathan Steven ALEXANDER, Christopher KEVIL, Mansoureh BARZEGAR, Ana Maria DRAGOI
  • Methods for treating c-Met-dependent cancers
    Patent number: 10959968
    Abstract: A method of treating cancer or a precancer condition in a mammal comprising administering a therapeutically effective amount of a homovanillyl sinapate analog or pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: March 30, 2021
    Assignee: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY
    Inventors: James Allen Cardelli, Ana-Maria Dragoi, Khalid El-Sayed, Mohamed M. Mohyeldin
  • Cancer treatment combination compositions, methods and uses
    Patent number: 10603335
    Abstract: The invention provides combinations and formulations including a luteinizing hormone-releasing hormone (LHRH) or a LHRH analog; and curcumin or a curcumin analog. LHRH or LHRH analog can be fused or conjugated to a curcumin or curcumin analog. Invention combinations and formulations can also include an anti-cell proliferative drug. Invention combinations and formulations can be used for inhibiting proliferation of a cell; treating a hyperproliferative disorder; and treating a neoplasia, tumor, cancer or malignancy.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: March 31, 2020
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: James Cardelli, Ana-Maria Dragoi
  • METHODS FOR TREATING C-MET-DEPENDENT CANCERS
    Publication number: 20190328690
    Abstract: A method of treating cancer or a precancer condition in a mammal comprising administering a therapeutically effective amount of a homovanillyl sinapate analog or pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.
    Type: Application
    Filed: January 13, 2017
    Publication date: October 31, 2019
    Inventors: James Allen CARDELLI, Ana-Maria DRAGOI, Khalid EL-SAYED, Mohamed M. MOHYELDIN
  • CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES
    Publication number: 20170258929
    Abstract: The invention provides combinations and formulations including a luteinizing hormone-releasing hormone (LHRH) or a LHRH analog; and curcumin or a curcumin analog. LHRH or LHRH analog can be fused or conjugated to a curcumin or curcumin analog. Invention combinations and formulations can also include an anti-cell proliferative drug. Invention combinations and formulations can be used for inhibiting proliferation of a cell; treating a hyperproliferative disorder; and treating a neoplasia, tumor, cancer or malignancy.
    Type: Application
    Filed: February 10, 2017
    Publication date: September 14, 2017
    Applicant: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: James CARDELLI, Ana-Maria DRAGOI